Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, researchers compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
In turn, these damaged cells are the targets of elimination by the immune system, which results in the production of endogenous injury-related molecular patterns and the release of cytokines
The Essential Fx Acyl-Glutathione Chia Cleansing Balm is designed to cleanse, replenish and nourish dry skin for a radiant, healthier-looking complexion
Tan X, Liang Y, Xie L, Gutierrez C, Harton J, Muhammad C, et al
With rising interest in GLP-1 for weight loss and metabolic health, this system was designed to activate GLP-1 in the body safely, helping your body produce its own GLP-1 hormones for better hunger control and energy balance
J Neuroinflammation 16(1):242 Fukuda S et al (2016) Glucagon-like peptide-1 strengthens the barrier integrity in primary cultures of rat brain endothelial cells under basal and hyperglycemia conditions